share_log

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25

HC Wainwright & Co.維持對Olema Pharmicals的買入,將目標股價下調至25美元
Moomoo 24/7 ·  03/12 06:39

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $28 to $25.

HC Wainwright & Co. 分析師艾米麗·博德納爾維持奧萊瑪製藥公司(納斯達克股票代碼:OLMA)的買入並將目標股價從28美元下調至25美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論